Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

Table 6 Incidence of treatment-related adverse events occurring during the whole study^a

Disorder type	ASAQ (n = 184)			AL (n = 182)
	Number (%)
	Mild	Moderate	Severe	Mild	Moderate	Severe
Blood and lymphatic	7 (3.8)	2 (1.1)	1 (0.5)	8 (4.4)	2 (1.1)	0 (0.0)
Gastrointestinal	7 (3.8)	2 (1.1)	0 (0.0)	6 (3.3)	1 (0.5)	0 (0.0)
Nervous	7 (3.8)	1 (0.5)	0 (0.0)	1 (0.5)	0 (0.0)	0 (0.0)
Skin, subcutaneous tissue	2 (1.1)	0 (0.0)	0 (0.0)	0 (0.0)	1 (0.5)	0 (0.0)
Respiratory, thoracic, mediastinal	2 (1.1)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
Hepatobiliary	1 (0.5)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
General	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (0.5)	0 (0.0)

ISSN: 1475-2875